Cutaneous Melanoma of the Extremity — Trials

Cutaneous Melanoma of the Extremity — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05628883	Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma	completed	Phase 1	17	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Apr 2, 2026	clinicaltrials

Data updated 23 days agoSource updated Apr 2, 2026source: clinicaltrials